Analytical Data
-
Gene name
FGFRL1
- Application
-
Alternative Names
FGFR5; FHFR; FGF homologous factor receptor; FGFR-like protein; Fibroblast growth factor receptor 5
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
Q91V87
-
Expression Region
Val164~Pro374
-
Molecular Weight
28kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FGFRL1 (Fibroblast Growth Factor Receptor-Like 1) is a member of the fibroblast growth factor receptor family and plays a critical role in various biological processes, including cell proliferation, differentiation, and migration. Unlike classical FGFRs, FGFRL1 lacks a functional kinase domain, suggesting that its mechanisms of action may differ from those of traditional receptors. Recent studies have highlighted the importance of FGFRL1 in modulating cellular responses to growth factors, as well as its potential involvement in tumorigenesis and tissue regeneration. Given that FGFRL1 has been implicated in several pathophysiological conditions, including cancer and cardiovascular diseases, researchers have focused on developing recombinant FGFRL1 proteins to better understand its biological functions and therapeutic potential. Recombinant FGFRL1 proteins allow scientists to study the receptor's structure-function relationships, investigate its interactions with ligands, and explore its signaling pathways. Moreover, these studies may pave the way for novel therapeutic strategies targeting FGFRL1, offering potential interventions for diseases linked to dysregulated FGF signaling. As the biotech community continues to unravel the complexities surrounding FGFRL1, the development of these recombinant proteins is essential for elucidating the receptor's role in health and disease.
